ArticlePloS one2026
Higher dietary polyphenol intake is associated with reduced pain sensitivity and migraine-related disability: A cross-sectional analysis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMigraine is a highly disabling neurological disorder characterized by recurrent headache attacks and altered pain processing. Emerging evidence suggests that dietary patterns rich in antioxidant compounds may modulate migraine-related pathophysiology, yet the specific association between polyphenol intake and objective pain sensitivity measures remains unclear. This study aimed to examine the association of dietary polyphenol with pain sensitivity and migraine-related disability in individuals with migraine. MATERIALS AND
methodsThis cross-sectional study including 72 adults (65 women) with a confirmed migraine diagnosis according to ICHD-III criteria. Participants completed a 3-day dietary record, and polyphenol intake was estimated using the Phenol-Explorer database. Clinical outcomes included pressure pain thresholds (PPTs) at trigeminal and extratrigeminal sites, migraine-related disability (MIDAS), perceived stress (PSS), and handgrip strength. Associations were analyzed using Pearson correlations and multiple linear regression models adjusted for age, sex, BMI, energy intake, and comorbidities.
resultsParticipants with longer disease duration reported higher polyphenol intake (p < 0.05). Total polyphenol intake was positively correlated with PPTs at the masseter (r = 0.27) and middle temporalis (r = 0.31), and inversely correlated with MIDAS scores (r = -0.25, all p < 0.05). In adjusted regression analyses, higher polyphenol intake predicted increased PPTs (masseter: β = 0.33; middle temporalis: β = 0.38) and lower MIDAS scores (β = -0.25, all p < 0.01). No associations were observed with handgrip strength or perceived stress.
conclusionsHigher dietary polyphenol intake was associated with reduced pain sensitivity and lower migraine-related disability, suggesting a potential role for polyphenol-rich diets in migraine management. Further randomized controlled trials are needed to confirm these associations and explore the mechanisms through which polyphenol-rich diets may influence migraine-related outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.